LaVoieHealthScience Adds Former Analyst & Welcomes New PR & IR Clients

LaVoieHealthScience Adds Former Analyst, Chiara Russo to Its Investor Relations Team

 

Welcomes New PR & IR Clients to its Roster

…LHS Makes Inc. 5000 List for 4th Time

 

Boston, MA – August 24, 2017 —  LaVoieHealthScience (LHS), an integrated investor and public relations agency focused on advancing health and science innovations, today announced that former specialty pharmaceutical analyst, Chiara Russo joined the LHS team as Director, Investor Relations. In addition, LHS announced new clients, the life science accelerator, Xontogeny LLC and electroceutical pioneer, Iota BioSciences.

Ms. Russo joins LHS from Cantor Fitzgerald, LLC, where she was Director, Research Analyst covering various small to mid-cap specialty pharma/biotech companies across a multitude of therapeutic areas leading to a significant industry network.  She has been quoted in many news outlets such as Bloomberg, Reuter, TheStreet and Bezinga and accompanied company executives on numerous non-deal roadshows in major investor centers.  Prior to her role at Cantor, Chiara was Vice President, Research Analyst at Janney Montgomery Scott, LLC, having started her career at Think Equity LLC.

“Continuing to add experienced health and science communications talent to our team is an important part of our strategy for growth,” said Donna L. LaVoie, President & CEO of LaVoieHealthScience. “With our continued focus in providing an integrated solution in both investor and public relations to our clients, adding Chiara to the team provides us with additional bench strength in IR and financial communications.”

“I am excited to already be applying my skills as an analyst to help LHS’ clients with story-telling and their investment thesis along with an insider’ view on how news is viewed and potential institutional targets,” said Russo.

Xontogeny LLC, founded by former Sarepta CEO and serial entrepreneur, Chris Garabedian, is a biotech aggregator that supports the accelerated development of life science technologies in the pursuit of helping patients with serious diseases.  Xontogeny partners with entrepreneurs, providing the leadership and operating experience needed to increase the probability of success with early drug and technology development.

Iota BioSciences, founded in Berkeley, CA, is an emerging electroceutical company revolutionizing the use of “vanishingly small” wireless, battery less sensors, bringing closer a time when a Fitbit-like device could monitor internal nerves, muscles, or organs in real time.

“As this is our fourth time making the Inc. 5000 fastest-growing private company list, we are proud of the team’s accomplishments and to add these clients to our list of movers and shakers in the health and sciences field,” said Donna LaVoie, President & CEO of LaVoieHealthScience. “The LHS team is excited to help these emerging health and science innovators add value and grow.”

 

About LaVoieHealthScience

LaVoieHealthScience partners with leading life science brands to build value for their companies, attract capital and reach key stakeholders through integrated communications and marketing. The firm provides strategic communications, investor relations and public relations to build recognition and increase sales and value for health science innovations. The agency has received 29 awards over the past seven years in recognition of the work it has done for its health and science industry-leading clients, and is ranked among the 2017 Inc. 5000 list of fastest growing private companies for the fourth year. In addition to clients listed above, LaVoieHealthScience represents leaders such as Biotechnology Innovation Organization, Cydan Development, Imara, NewLink Genetics, Newron Pharmaceuticals, Origenis, and other emerging health and science companies.

###

Contact:
Beth Kurth
Vice President, Investor Relations
bkurth@lavoiehealthscience.com
617-374-8800 x106

LaVoieHealthScience Clients Recognized by Xconomy

 LaVoieHealthScience Clients Recognized by Xconomy

LEO Science & Tech Hub and Xontogeny Selected as Award Finalists

LaVoieHealthScience, an integrated investor and public relations agency focused on advancing health and science innovations, today announced that two clients, LEO Science & Tech Hub and Xontogeny are finalists for the 2017 Xconomy awards!  The Xconomy awards honor the top people, companies and organizations that make the Boston life sciences community one of the most vibrant innovation centers in the world during Biotech Week Boston.

Chris Garabedian, CEO of Xontogeny is a finalist in the Contrarian category and LEO Science & Tech Hub in the Newcomer category.

The Xconomy Awards are part of the Biotech Week in Boston and will be presented at the awards gala on September 26th.

About LaVoieHealthScience

LaVoieHealthScience partners with leading life science brands to build value for their companies, attract capital and reach key stakeholders through integrated communications and marketing. The firm provides strategic communications, investor relations and public relations to build recognition and increase sales and value for health science innovations. The agency has received 28 awards over the past seven years in recognition of the work it has done for its health and science industry-leading clients. In addition to clients listed above, LaVoieHealthScience represents leaders such as Cydan Development, Imara, NewLink Genetics, Biotechnology Innovation Organization, Newron Pharmaceuticals, Origenis, and other emerging health and science companies.

Donna LaVoie to Present “The LHS Fifteen-Slide Presentation®” at Venture Cafe

You’re Invited: “The LHS Fifteen-Slide Presentation®

 

Venture Café at The Cambridge Innovation Center (CIC)

Thursday, August 24, 5:30 – 6:30 p.m.

 

You are invited to join Donna LaVoie, President & CEO of LaVoieHealthScience, for her trademarked workshop “The LHS Fifteen-Slide Presentation®” on August 24 from 5:30-6:30 pm ET at the Venture Cafe, One Broadway, Kendall Square, Cambridge. First presented at BIO International in 2016, the workshop was offered again in 2017 to a standing-room-only crowd and is now available on the East Coast!

This workshop covers how to create an engaging company presentation in just 15 slides.   At this interactive session, attendees will learn:

  • The basics of a great presentation including slides to cover the science and business strategy
  • The qualities of a great presentation including how to be both succinct and specific

To prepare for the workshop, attendees can download and fill out the “Creating Your Elevator Pitch” worksheet by following the link below. This document is the first essential part of crafting effective presentation slides.

Please RSVP to Ryan Donovan, rdonovan@lavoiehealthscience.com

We look forward to seeing you.

 

One Great Day, Two Great San Diego Workshops

Monday, June 19; One Great Day, Two Great San Diego Workshops

Tales from the Biotech/Medtech Road and 15 Slides to Glory

Angus McQuilken, Vice President for Public Affairs, will be moderating a panel on June 19 at 9:00 am PT, Tales from the Road, at Redefining Early Stage Investments (RESI), San Diego.  The panel will feature four life science entrepreneurs who will share their experience with fundraising. The panel will focus on tactics, and the audience will leave with new tools and information to help them along with their own fundraising efforts. The panel includes Magda Marquet, Chairman & Co-Founder, AltheaDx; Michael Tippie, CEO, Lipidomics; Mike Moradi, Co-Founder & CEO, Sensulin; Joyce Lonergan, Founder & CEO, Mellitus.

Donna LaVoie, President & CEO, will be hosting a workshop on June 19 at 2:30 pm PT at BIO International in San Diego, “15 Slides to Glory: How to Create Your Company Presentation.” It will cover how to create an essential company presentation in just 15 slides. Attendees will participate in an interactive session to learn about the basics of effective public speaking, including the importance of avoiding information overload.  As preparation for this session, please download, read, and fill out, the brief worksheet linked below on “Creating Your Elevator Pitch,” the first essential part of crafting effective presentation slides. This session will include audience members sharing their elevator pitches and getting live feedback on which elements work well and which need improvement. WORKSHEET LINK: http://bit.ly/BIO-ElevPitch

 

Donna L. LaVoie to Deliver Workshop at BIO International on the LHS 15-Slide Presentation™

Donna L. LaVoie to Deliver Workshop at BIO International on the LHS 15-Slide Presentation™

How to Develop a Corporate Presentation in Just 15 Slides

Boston – June 5, 2017 – Donna L. LaVoie, president and CEO of LaVoieHealthScience (LHS), an award-winning integrated strategic communications agency focused on health and life science, will be presenting at BIO International in San Diego on June 19 at 2:30 p.m. PT. Donna will be delivering a workshop, “15 Slides to Glory: How to Create your Company Presentation,” the LHS trademarked process of creating a corporate deck in just fifteen slides.

“I am very happy to return to BIO International to lead this workshop on developing key message pillars to engage with stakeholders,” she said. “To run your business successfully you need clear and concise messaging, and the LHS 15-Slide Presentation™ helps to do just that.”

The BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO). BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.

LaVoieHealthScience has worked with BIO to develop a thought leadership series of videos on public speaking covering The LHS 15-Slide Presentation™, Public Speaking Strategies for the CEO and Creating Your Elevator Pitch. More information on this series can be found here.

About LaVoieHealthScience
LaVoieHealthScience provides strategic communications, investor relations and public relations to build recognition and increase sales and value for health science innovations to improve humankind. The agency has received 28 awards over the past seven years in recognition of the work it has done for its health and science industry-leading clients. The agency ranks among the 2016 Inc. 5000 list of fastest growing private companies and among the Top 30 Independent Healthcare Firms as ranked by O’Dwyer’s PR.

###

Contact:
Beth Kurth
Vice President, Investor Relations
bkurth@lavoiehealthscience.com
617-374-8800 x106

LaVoieHealthScience Announces Addition to Strategic Communications Team

Andrew Mastrangelo hired as Assistant Vice President, Public & Media Relations

Boston, Mass. – April 25, 2017 –
LaVoieHealthScience (LHS), an integrated strategic communications agency focused on the health and life science industries, announced the appointment of Andrew Mastrangelo as Assistant Vice President, Public & Media Relations. Andrew is based at the agency’s Boston, Mass. headquarters and reports to Vice President of Integrated Communications, Sharon Correia.

“I am excited to have Andrew on the LaVoieHealthScience team,” said Sharon Correia. “Andrew brings invaluable experience and insight in the health field, as well as media strategy, crisis communications and content development capability.  We look forward to him making an immediate impact by leveraging his experience in multidisciplinary storytelling to identify new opportunities and maximize the depth and breadth of coverage for our clients.”

Andrew, who has broad-based experience–across industries and communications disciplines–will lead media strategy across all accounts. Andrew was previously the Director of Media Relations & Public Information Officer for Lahey Health, where he led the external communications efforts for each of the five Lahey Health hospitals, as well as the brand itself.  At Lahey Health he was also responsible for management and clinician spokesperson development and scientific outreach. Prior to Lahey Health, he served as the Director of Corporate Communications at Allen & Gerritsen (a&g), the largest independent advertising agency in Boston, where he oversaw and shaped all forms of internal, external, digital and social, and HR communications.

“LaVoieHealthScience is at the forefront of strategic communications for the health & science industries, and I am thrilled to join the team,” said Andrew Mastrangelo. “This position provides a wonderful opportunity for me to leverage the remarkable creativity and innovative thinking that LaVoieHealthScience has to offer to continue driving business results for all our clients.  I am eager to get started.”

About LaVoieHealthScience
LaVoieHealthScience provides strategic communications, investor relations and public relations to build recognition and increase sales and value for health science innovations to improve humankind. The agency has received 28 awards over the past seven years in recognition of the work it has done for its health and science industry-leading clients. The agency ranks among the 2016 Inc. 5000 list of fastest growing private companies and among the Top 30 Independent Healthcare Firms as ranked by O’Dwyer’s PR.

Contact
LaVoieHealthScience
Sharon Correia
Vice President
(617) 374-8800, x105
scorreia@lavoiehealthscience.com
www.lavoiehealthscience.com